Jeffrey Harte

Statistics

Publications

Citations

H-Index

Active since

2019

Affiliations

Jeffrey Harte is an author at TUM Klinikum specializing in pharmacotherapy, central nervous system tumor pharmacotherapy, and neuro-oncology clinical trials.

ORCID

Publications per year

2019–2023

Publications

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

Marius Trøseid, José Ramón Arribas, Lambert Assoumou et al. · Critical Care · 2023 · 47 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma

Jack P. Gleeson, Fergus Keane, Niamh M. Keegan et al. · Cancer Medicine · 2019 · 21 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

1–2 of 2